Viewing Study NCT01956669


Ignite Creation Date: 2025-12-24 @ 11:00 PM
Ignite Modification Date: 2026-02-26 @ 2:18 AM
Study NCT ID: NCT01956669
Status: COMPLETED
Last Update Posted: 2020-08-12
First Post: 2013-08-01
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Sponsor: Novartis Pharmaceuticals
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 116731
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NETWORK View